David Berz

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Karen L. Reckamp, Vladislava O. Melnikova, Chris Karlovich et al. · Journal of Thoracic Oncology · 2016 · 285 citations · Full text

Medicine, Oncology, Pharmacology +17

Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription

Jason M. Aliotta, Mandy Pereira, Kevin W. Johnson et al. · Experimental Hematology · 2010 · 206 citations

Life Sciences, Cell Biology, Molecular Biology +9

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih‐Hsin Yang, D. Ross Camidge, Cheng‐Ta Yang et al. · Journal of Thoracic Oncology · 2020 · 156 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism

Gerald A. Colvin, David Berz, Muthalagu Ramanathan et al. · Biology of Blood and Marrow Transplantation · 2009 · 73 citations · Full text

Medicine, Hematology, Oncology +17

Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature

Cannon Milani, Maria Constantinou, David Berz et al. · Journal of Hematology & Oncology · 2008 · 58 citations · Full text

Medicine, Hematology, Radiology +15